DuPont de Nemours (NYSE:DD) Given New $49.00 Price Target at UBS Group

DuPont de Nemours (NYSE:DD) had its price objective raised by equities research analysts at UBS Group from $46.00 to $49.00 in a research note issued on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the basic materials company’s stock. UBS Group’s target price indicates a potential upside of 13.38% from the company’s current price.

A number of other research firms have also recently weighed in on DD. Royal Bank Of Canada cut their price target on DuPont de Nemours from $100.00 to $48.00 and set an “outperform” rating on the stock in a report on Tuesday, November 18th. Citigroup lifted their target price on DuPont de Nemours from $38.90 to $47.00 and gave the company a “buy” rating in a research note on Friday, November 7th. KeyCorp decreased their price target on DuPont de Nemours from $93.00 to $44.00 and set an “overweight” rating for the company in a research note on Wednesday, November 5th. Zacks Research cut shares of DuPont de Nemours from a “hold” rating to a “strong sell” rating in a research note on Tuesday, October 14th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of DuPont de Nemours from $104.00 to $48.00 and set an “overweight” rating for the company in a report on Tuesday, November 11th. Ten investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $44.07.

DuPont de Nemours Stock Performance

Shares of DD traded down $0.22 during midday trading on Wednesday, hitting $43.22. 2,286,080 shares of the stock traded hands, compared to its average volume of 4,359,511. DuPont de Nemours has a 1-year low of $22.50 and a 1-year high of $43.69. The firm has a market capitalization of $18.11 billion, a PE ratio of -23.50, a price-to-earnings-growth ratio of 3.11 and a beta of 1.08. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.63 and a current ratio of 2.00. The business’s 50 day moving average price is $39.67 and its two-hundred day moving average price is $34.45.

DuPont de Nemours (NYSE:DD) last released its quarterly earnings data on Monday, July 11th. The basic materials company reported $0.29 earnings per share for the quarter. The business had revenue of $3.02 billion for the quarter. DuPont de Nemours had a negative net margin of 6.17% and a positive return on equity of 7.81%. Equities research analysts predict that DuPont de Nemours will post 4.38 EPS for the current fiscal year.

DuPont de Nemours declared that its Board of Directors has authorized a stock buyback plan on Thursday, November 6th that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the basic materials company to reacquire up to 12.2% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s leadership believes its stock is undervalued.

Insider Transactions at DuPont de Nemours

In other DuPont de Nemours news, CEO Lori Koch sold 9,011 shares of the business’s stock in a transaction dated Friday, November 28th. The shares were sold at an average price of $39.46, for a total value of $355,574.06. Following the sale, the chief executive officer directly owned 288,326 shares in the company, valued at approximately $11,377,343.96. The trade was a 3.03% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Erik T. Hoover sold 6,005 shares of the company’s stock in a transaction dated Friday, November 28th. The shares were sold at an average price of $39.79, for a total transaction of $238,938.95. Following the completion of the sale, the senior vice president directly owned 112,101 shares of the company’s stock, valued at $4,460,498.79. The trade was a 5.08% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.61% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Princeton Global Asset Management LLC grew its holdings in shares of DuPont de Nemours by 64.4% during the second quarter. Princeton Global Asset Management LLC now owns 365 shares of the basic materials company’s stock valued at $25,000 after buying an additional 143 shares in the last quarter. Salomon & Ludwin LLC boosted its position in DuPont de Nemours by 186.5% during the 3rd quarter. Salomon & Ludwin LLC now owns 318 shares of the basic materials company’s stock worth $25,000 after acquiring an additional 207 shares during the period. Palisade Asset Management LLC purchased a new position in DuPont de Nemours during the 3rd quarter valued at about $26,000. Financial Life Planners acquired a new position in shares of DuPont de Nemours in the 3rd quarter valued at about $27,000. Finally, Imprint Wealth LLC acquired a new position in shares of DuPont de Nemours in the 3rd quarter valued at about $27,000. Institutional investors and hedge funds own 73.96% of the company’s stock.

DuPont de Nemours Company Profile

DuPont de Nemours (NYSE: DD) is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.

DuPont’s operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.